Karlstad University, Karlstad, Sweden.
Acta Odontol Scand. 2009;67(6):370-6. doi: 10.1080/00016350903136613.
The aim of the present study was to examine the impact of general diseases and medication on oral health-related quality of life (OHRQoL) in a Swedish adult population using the Swedish version of Oral Impacts on Daily Performances (OIDP).
A three-site sample of 200 adults (20-86 years; participation rate 70%) was interviewed using the OIDP, and a medical anamnesis was performed in 2006-7. A self-reported questionnaire provided complementary socio-economic data.
The burden of medical diagnoses and medications was greatest among the older participants in the study. The mean number of medicines in regular users was: ≥60 years, 3.6 (SD 2.6); 40-59 years, 1.9 (SD 1.5); and 20-40 years, 1.9 (SD 1.8) (p =0.013). There were no gender differences in general health or medication variables. Self-reported health, medical diagnoses and medication were significantly and consistently associated with the OIDP score: subjects with ≥1 diagnosis, OR 2.22 (95% CI 1.19-4.14) and subjects with ≥1 medicines, OR 1.85 (95% CI 1.01-3.40) versus those without diagnoses or medication. However, there was a clear gradient: OIDP scores increased with increasing numbers of diagnoses and medicines.
The Swedish version of the OIDP was found useful for measuring impacts of general health and medication on OHRQoL. Dental care should pay special attention to patients with medical conditions or who are on medication, because these patients are more likely to experience oral impacts on daily performances.
本研究旨在使用瑞典版 Oral Impacts on Daily Performances(OIDP)评估一般疾病和药物对瑞典成年人口腔健康相关生活质量(OHRQoL)的影响。
在 2006-7 年期间,对 200 名成年人(20-86 岁;参与率为 70%)进行了三个地点的样本访谈,使用 OIDP,并进行了医学病史调查。一份自我报告的问卷提供了补充的社会经济数据。
研究中年龄较大的参与者的医疗诊断和药物负担最大。经常使用药物的患者的平均用药数量为:≥60 岁,3.6(SD 2.6);40-59 岁,1.9(SD 1.5);20-40 岁,1.9(SD 1.8)(p =0.013)。一般健康状况或药物变量在性别方面没有差异。自我报告的健康状况、医疗诊断和药物与 OIDP 评分显著且一致相关:≥1 种诊断的患者,OR 2.22(95%CI 1.19-4.14)和≥1 种药物的患者,OR 1.85(95%CI 1.01-3.40)与无诊断或药物的患者相比。然而,存在明显的梯度:随着诊断和药物数量的增加,OIDP 评分增加。
发现瑞典版 OIDP 可用于测量一般健康和药物对 OHRQoL 的影响。牙科护理应特别关注患有疾病或正在服用药物的患者,因为这些患者更有可能经历对日常表现的口腔影响。